Your browser doesn't support javascript.
X-linked Charcot-Marie-Tooth disease after SARS-CoV-2 vaccination mimicked stroke-like episodes: A case report.
Zhang, Qiang; Wang, Yang; Bai, Run-Tao; Lian, Bao-Rong; Zhang, Yu; Cao, Li-Ming.
  • Zhang Q; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, Guangdong Province, China.
  • Wang Y; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, Guangdong Province, China.
  • Bai RT; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, Guangdong Province, China.
  • Lian BR; Shantou University Medical College, Shantou University, Shantou 515063, Guangdong Province, China.
  • Zhang Y; Clinical College of The Shenzhen Second People's Hospital, Anhui Medical University, Shenzhen 518000, Guangdong Province, China.
  • Cao LM; Department of Neurology, The First Affiliated Hospital of Shenzhen University, Shenzhen 518000, Guangdong Province, China.
World J Clin Cases ; 11(2): 464-471, 2023 Jan 16.
Article in English | MEDLINE | ID: covidwho-2217646
ABSTRACT

BACKGROUND:

Severe acute respiratory syndrome coronavirus 2 (SARS-CoV-2) vaccinations have been administered worldwide, with occasional reports of associated neurological complications. Specifically, the impact of vaccinations on individuals with X-linked Charcot-Marie-Tooth disease type 1 (CMTX1) is unclear. Patients with CMTX1 can have stroke-like episodes with posterior reversible encephalopathy syndrome on magnetic resonance imaging (MRI), although this is rare. CASE

SUMMARY:

A 39-year-old man was admitted with episodic aphasia and dysphagia for 2 d. He received SARS-CoV-2 vaccination 39 d before admission. Physical examination showed pes cavus and reduced tendon reflexes. Brain MRI showed bilateral, symmetrical, restricted diffusion with T2 hyperintensities in the cerebral hemispheres. Nerve conduction studies revealed peripheral nerve damage. He was diagnosed with Charcot-Marie-Tooth disease, and a hemizygous mutation in the GJB1 gene on the X chromosome, known to be pathogenic for CMTX1, was identified. Initially, we suspected transient ischemic attack or demyelinating leukoencephalopathy. We initiated treatment with antithrombotic therapy and immunotherapy. At 1.5 mo after discharge, brain MRI showed complete resolution of lesions, with no recurrence.

CONCLUSION:

SARS-CoV-2 vaccination could be a predisposing factor for CMTX1 and trigger a sudden presentation.
Keywords

Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Etiology study Topics: Vaccines Language: English Journal: World J Clin Cases Year: 2023 Document Type: Article Affiliation country: Wjcc.v11.i2.464

Similar

MEDLINE

...
LILACS

LIS


Full text: Available Collection: International databases Database: MEDLINE Type of study: Case report / Etiology study Topics: Vaccines Language: English Journal: World J Clin Cases Year: 2023 Document Type: Article Affiliation country: Wjcc.v11.i2.464